132 related articles for article (PubMed ID: 14522012)
1. Structural analysis of IgG2A monoclonal antibodies in relation to complement deposition and renal immune complex deposition.
Gonzalez ML; Frank MB; Ramsland PA; Hanas JS; Waxman FJ
Mol Immunol; 2003 Oct; 40(6):307-17. PubMed ID: 14522012
[TBL] [Abstract][Full Text] [Related]
2. Relationship between complement activation and renal deposition of immune complexes made with IgG2a monoclonal antibodies.
Gonzalez ML; Waxman FJ
Clin Immunol; 2001 Sep; 100(3):362-71. PubMed ID: 11513550
[TBL] [Abstract][Full Text] [Related]
3. Glomerular deposition of immune complexes made with IgG2a monoclonal antibodies.
Gonzalez ML; Waxman FJ
J Immunol; 2000 Jan; 164(2):1071-7. PubMed ID: 10623858
[TBL] [Abstract][Full Text] [Related]
4. Clonal variations in complement activation and deposition of C3b and C4b on model immune complexes.
Yokoyama I; Waxman F
Immunology; 1993 Oct; 80(2):168-76. PubMed ID: 8262546
[TBL] [Abstract][Full Text] [Related]
5. Isotypic and clonal variations in the interactions between model monoclonal immune complexes and the human erythrocyte CR1 receptor.
Yokoyama I; Waxman F
Mol Immunol; 1992; 29(7-8):935-47. PubMed ID: 1386141
[TBL] [Abstract][Full Text] [Related]
6. Genetic, structural and functional properties of an IgG DNA-binding monoclonal antibody from a lupus patient with nephritis.
Ravirajan CT; Rahman MA; Papadaki L; Griffiths MH; Kalsi J; Martin AC; Ehrenstein MR; Latchman DS; Isenberg DA
Eur J Immunol; 1998 Jan; 28(1):339-50. PubMed ID: 9485213
[TBL] [Abstract][Full Text] [Related]
7. Effect of immunoglobulin variable region structure on C3b and C4b deposition.
White KD; Frank MB; Foundling S; Waxman FJ
Mol Immunol; 1996 Jun; 33(9):759-68. PubMed ID: 8811071
[TBL] [Abstract][Full Text] [Related]
8. The covalent interaction of C3 with IgG immune complexes.
Vivanco F; Muñoz E; Vidarte L; Pastor C
Mol Immunol; 1999; 36(13-14):843-52. PubMed ID: 10698338
[TBL] [Abstract][Full Text] [Related]
9. The complement-fixing activity of immune complexes containing IgG antibodies of different functional affinities: effects on superoxide production by rabbit neutrophils.
Alves CM; Marzocchi-Machado CM; Azzolini AE; Lucisano-Valim YM
Immunol Invest; 2004 Feb; 33(1):39-50. PubMed ID: 15015831
[TBL] [Abstract][Full Text] [Related]
10. Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants.
Dashivets T; Thomann M; Rueger P; Knaupp A; Buchner J; Schlothauer T
PLoS One; 2015; 10(12):e0143520. PubMed ID: 26657484
[TBL] [Abstract][Full Text] [Related]
11. The effects of immunoglobulin isotype and antibody affinity on complement-mediated inhibition of immune precipitation and solubilization.
Johnson A; Harkin S; Steward MW; Whaley K
Mol Immunol; 1987 Nov; 24(11):1211-7. PubMed ID: 3696168
[TBL] [Abstract][Full Text] [Related]
12. Effect of H chain V region on complement activation by immobilized immune complexes.
Horgan C; Brown K; Pincus SH
J Immunol; 1992 Jul; 149(1):127-35. PubMed ID: 1607649
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of antigen complexed with antibody. I. Role of different isotypes.
Farkas AI; Medgyesi GA; Füst G; Miklós K; Gergely J
Immunology; 1982 Mar; 45(3):483-92. PubMed ID: 7061107
[TBL] [Abstract][Full Text] [Related]
14. Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent.
Beiboer SH; Reurs A; Roovers RC; Arends JW; Whitelegg NR; Rees AR; Hoogenboom HR
J Mol Biol; 2000 Feb; 296(3):833-49. PubMed ID: 10677285
[TBL] [Abstract][Full Text] [Related]
15. The influence of antibody functional affinity on the effector functions involved in the clearance of circulating immune complexes anti-BSA IgG/BSA.
Marzocchi-Machado CM; Polizello AC; Azzolini AE; Lucisano-Valim YM
Immunol Invest; 1999; 28(2-3):89-101. PubMed ID: 10484684
[TBL] [Abstract][Full Text] [Related]
16. An engineered Fc variant of an IgG eliminates all immune effector functions via structural perturbations.
Vafa O; Gilliland GL; Brezski RJ; Strake B; Wilkinson T; Lacy ER; Scallon B; Teplyakov A; Malia TJ; Strohl WR
Methods; 2014 Jan; 65(1):114-26. PubMed ID: 23872058
[TBL] [Abstract][Full Text] [Related]
17. The effect of antibody isotype and antigenic epitope density on the complement-fixing activity of immune complexes: a systematic study using chimaeric anti-NIP antibodies with human Fc regions.
Lucisano Valim YM; Lachmann PJ
Clin Exp Immunol; 1991 Apr; 84(1):1-8. PubMed ID: 1707767
[TBL] [Abstract][Full Text] [Related]
18. Structural characterization of an (NZB x NZW)F1 mouse-derived IgM monoclonal antibody that binds through V region-dependent interactions to murine IgG anti-DNA antibodies.
Margaritte C; Gilbert D; Brard F; Tron F
J Autoimmun; 1994 Dec; 7(6):711-25. PubMed ID: 7888030
[TBL] [Abstract][Full Text] [Related]
19. Deposition of the lectin pathway of complement in renal biopsies of lupus nephritis patients.
Nisihara RM; Magrini F; Mocelin V; Messias-Reason IJ
Hum Immunol; 2013 Aug; 74(8):907-10. PubMed ID: 23639552
[TBL] [Abstract][Full Text] [Related]
20. Mutant monoclonal antibodies with select alteration in complement activation ability. Impact on immune complex functions in vivo.
Nose M; Okuda T; Gidlund M; Ramstedt U; Okada N; Okada H; Heyman B; Kyogoku M; Wigzell H
J Immunol; 1988 Oct; 141(7):2367-73. PubMed ID: 3171176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
